We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

PTAB Denies Coherus' Challenge To 2 Enbrel Patents

Law360 (March 12, 2018, 7:42 PM EDT) -- The Patent Trial and Appeal Board on Friday shot down Coherus BioSciences’ request to reevaluate two patents owned by Hoffman-LaRoche Inc., which are licensed to Amgen Inc. for its blockbuster immunosuppressant...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.